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BACKGROUND:  It  has  been  shown  that  cells  of  the
immune system release opioid peptides and possess
receptors  for  them.  The  concentrations  of  opioid
peptides  in  the  peripheral  circulation  rapidly
increase  during  inflammation  and  acute  stress
response.
Aims: The effect of opioid peptides Met-enkephalin
(M-ENK) and beta-endorphin (b -END) on the oxida-
tive  metabolism of normal human neutrophils and
their death by apoptosis in vitro was investigated. 
Methods: Isolated from peripheral blood, neutrophils
were incubated in the presence or absence of 10–6 to
10–10 M of M-ENK and b-END for 12 and 18h. Apopto-
sis  of neutrophils was determined in  vitro by flow
cytometric  analysis  of  cellular  DNA  content  and
Annexin V-FITC protein binding to the cell surface.
The MTT-reduction assay was employed to estimate
the oxidative metabolism of neutrophils.
Results: Treatment with M-ENK caused a significant
increase in apoptotic cells after 18h of culture: *0M
(control)  versus  10–10 M,  p £   0.02;  **10–10 M  versus
10–10 M,  p £   0.02.  Treatment  with  b -END  caused  a
significant  increase  in  apoptotic  cells  after  12h  of
culture:  0M  versus  10–8 M,  p £   0.03;  **0M  versus
10–10 M, p £  0.04. We found the significant increase in
MTT  reduction  by  neutrophils  in  the  presence  of
M-ENK and b -END both before and after the culture.
However, the ability of neutrophils to reduce the MTT
salt  to  formazan  decreased  significantly  after  the
culture.
Conclusions: We observed that the in vitro effect of
opioid peptides on the neutrophil survival and their
functional state was time and dose dependent. The
presence  of  antioxidants  in  the  culture  medium
modifies neutrophil survival.
Key  words:  Apoptosis,  Opioid  peptides,  Human  poly-
morphonuclear leukocytes (neutrophils), Reactive oxygen
species
Introduction
The response of an organism to infection and stress
involves  bidirectional  communication  between  the
immune and neuroendocrine systems. Both systems
communicate through various mechanisms including
common signal and recognition molecules.  Cells of
the immune system possess receptors for endocrine
hormones  and  neuropeptides,  and  can  also  be  a
source of them.1–5 Secreted by  immune  cells,  neu-
ropeptides may function as endogenous regulators of
the  immune  system.6 The  endogenous  opioid  pep-
tides are the peptides derived from a precursor called
pro-opiomelanocortin that is present in immune cells
as well as in the hypothalamus and pituitary.7 Mainly
enkephalins,  endorphins  and  dynorphins  represent
the  endogenous  opioid  peptides.  Endorphins  and
enkephalins  share  a  common  N-terminal  sequence
consisting of five amino acids Tyr-Gly-Gly-Phe-Met or
Leu that are responsible for their biological activity.
They  differ  in  molecular  size.  Met-enkephalin
(M-ENK)  is  a  pentapeptide,  and  beta-endorphin
(b-END)  is  composed  of  31  amino  acids.8 Stress
response and inflammation  are  associated with the
release of high levels of opioid peptides into systemic
circulation.9
Polymorphonuclear  neutrophils  (PMNs)  are
involved in the response to invasion of the host by
bacteria, viruses and fungi. The production of reactive
oxygen  species  (ROS),  including  superoxide  anion
(O2
–)  and  hydrogen  peroxide  (H2O2)  and  nitric
oxide, is considered to play  a key role in  the host
defense against invading microorganisms, but can also
be responsible for tissue damage.10,11 To respond to
the tissue inflammation, the neutrophils migrate into
the  inflamed  site  where  they  are  exposed  to  the
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Apoptosis, also called programmed cell death, plays
a critical role in the resolution of inflammation and in
the regulation of the host immune response. Normal
human neutrophils spontaneously undergo apoptosis
in  vitro and  in  vivo.  Apoptosis  of  the  activated
neutrophils  has  been  suggested  as  an  important
mechanism  for  their  removal  from  inflammatory
sites.12,13 The  modulation  of  this  process  is  very
important  for  maintaining  the  balance  between
defense and injury. There is evidence suggesting that
oxidative stress plays a pivotal role in the induction of
apoptosis in neutrophils.14–17 It has been shown that
opioid  peptides,  such  as  M-ENK  or  b-END,  like
inflammatory  cytokines,  may  prime  neutrophils  to
enhanced response after subsequent challenge with
specific activation.18,19 So, opioid peptides like many
others  agents  that  prime  or  activate  human  neu-
trophils  can  affect,  or  not,  spontaneous neutrophil
apoptosis in vitro.
The aim of the present study was to evaluate the
possibility of whether ROS released by neutrophils as
a consequence of the activation with opioid peptides
may  promote  their  own  death  by  apoptosis. The
neutrophil apoptosis as an in vitro model to inves-
tigate the effect of exogenous opioid peptides on the
neutrophil survival was used.
Materials and methods
Reagents
M-ENK,  b-END,  naloxone,  trypan  blue,  propidium
iodide  (PI),  3-(4,5-diethylthiazol-2-yl)2,5-diphenylte-
trazolium  bromide  (MTT),  phorbol  12-myristate
13-acetate (PMA), superoxide dismutase (SOD), cata-
lase  (CAT),  fetal  calf  serum  (FCS),  100U/ml  of
penicillin  and 100mg/ml  of streptomycin, ethylene-
diamine tetraacetate (EDTA), Ribonuclease A (RNase
A),  and  tumor  necrosis  factor-alpha  (TNF-a)  were
obtained from Sigma (Sigma Chemical Co., St Louis,
MO, USA). Phosphate-buffered saline (PBS) and RPMI
1640 were purchased from Biomed (Lublin, Poland).
Gradisol G (specific gravity, 1.115g/ml) was obtained
from Polfa (Kutno, Poland). The Annexin V/FITC Kit
was purchased from Bender MedSystems Diagnostics
GmbH (Vienna, Austria). Twenty-four-well or 96-well
flat-bottom plates were from NUNC Brand Products
(Roskilde,  Denmark).  May-Gr¨ unwald-Giemza  dyes
were purchased from AQUA-MED (Lodz, Poland). Izo-
propanol  (2-propanol)  was  obtained  from  POCH
(Gliwice, Poland).
Cell preparation
PMN  (neutrophils)  were  isolated  from  heparinized
peripheral  blood  collected  from  healthy  donors
using  a  one-step  density-gradient  centrifugation  on
Gradisol  G  at  400  ´ g  at  room  temperature  for
30min.  The  residual  erythrocytes  were  removed
from  the  cell  population  by  hypotonic  lysis.  The
neutrophils were washed twice and resuspended in
PBS.20 The cell suspensions were stored in PBS at a
concentration of 1 ´ 106 or 2 ´ 106/ml at 4°C and
used  within  2h.  Cell  purity  (>98%)  and  viability
(>98%)  were  determined  by  May-Gr¨ unwald-Giemsa
staining  of  cytocentrifuged  samples  and  by Trypan
blue exclusion, respectively.
Informed  consent was  obtained from  all  donors.
The Local Ethical Committee accepted this study.
Culture conditions of normal human
neutrophils
Neutrophils were maintained in RPMI 1640  supple-
mented  with  10%  FCS  and  antibiotics  (100U  of
penicillin and 100mg/ml of streptomycin). Either 2ml
or 200ml of cell suspension (1 ´ 106/ml) were placed
in 24-well or 96-well  plates, respectively, and dupli-
cate  and  triplicate  conditions  were  cultured  in
humidified  atmosphere  at  37°C  with  5%  CO2 for
varying  periods  of  time  as  indicated.  Neutrophil
suspensions were incubated in the absence (control
cell samples) or presence of 10–6 to 10–10 M of M-ENK
and b-END for 12 and 18h, and next washed once in
PBS. Aliquots  were  removed and  used  in  assays  of
neutrophil apoptosis and MTT reduction.
MTT-reduction assay
As a positive control of the activation-induced model
of a process referred to as oxidative burst, marked by
H2O2 and O2
– production, the cells treated with PMA
and TNF-a were used. The potency of PMN to produce
ROS  was  measured  as  their  ability  to  reduce  the
tetrazolium salt MTT to formazan by a colorimetric
method as previously described.21 Briefly, neutrophils
(2 ´ 105/well) were placed in 96-well plates in 150ml
of RPMI 1640 with 10% of FCS and PMA (100ng/ml),
TNF-a (10ng/ml), or tested opioid peptides at con-
centrations  as  indicated,  in  triplicate,  respectively.
Then, 50ml  of  MTT solution in  PBS (1mg/ml)  was
added to  each  well.  In  experiments  with  cultured
neutrophils at the end of the culture period, the MTT
solution  was  added  to  each  well. The  plates  were
centrifuged at 1000rpm for 1min and incubated for
1h  at  37°C  and  5%  CO2.  The  plates  were  then
centrifuged  for  15min  at 2000rpm,  and the super-
natants were removed by rapid inversion. Formazan
produced  by  PMN  in  each  well  was  dissolved  in
100ml of 2-propanol. An enzyme-linked immunosor-
bent assay  reader (Multiskan  MS, Helsinki,  Finland)
measured optical densities at dual wavelengths (540
and 620nm).
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Measurement of fluorescein isothiocyanate-labeled
Annexin V binding to the cell surface
The major change associated with the cell during the
early  phases of  apoptosis is  the  loss  of  membrane
phospholipid  asymmetry.  This  event  leads  to  the
translocation  of  phosphatidylserine  (PS)  from  the
inner  side  of  the  cell  membrane  to  the  outer
membrane.22,23 Cells  expressing  PS  at  the  plasma
membrane  bind  fluorescein  isothiocyanate-labeled
Annexin V (ANX-FITC), and cells with compromised
membrane  incorporate  and  bind  PI  to  the  cellular
DNA (Fig.  1A).24 The  percentage of apoptotic neu-
trophils was determined using  the binding of ANX-
FITC  protein  to  the  cell  surface  according  to  the
manufacturer’s specification. Specific binding of ANX-
FITC  was  performed  by  incubation  of  the  cell
suspension (1 ´ 105 cells) in 100ml of binding buffer
with 2ml of ANX-FITC and 10ml of PI (final concentra-
tion,  1mg)  for  25min  in  the  dark  at  room  tem-
perature. After incubation, the cells were centrifuged
and analyzed using a FACScan flow cytometer (Becton
Dickinson, Heidelberg, Germany) equipped with Cell
Quest software for cell acquisition and data analysis.
Analysis of DNA content by PI staining and flow
cytometry
DNA  content  was  analyzed  by  flow  cytometry  PI
staining as previously described by Nicoletti et al.25
with a slight modification.26 The method is based on
the fact that endonuclease activation leads to generat-
ing  low  molecular  weight  DNA  (LMW-DNA)  frag-
ments  during  apoptosis.  After  membrane  perme-
abilization LMW-DNA leaks out, resulting in decreased
DNA  content  in  apoptotic  cells,  while  the  DNA
content in non-apoptotic cells remains unchanged.
Briefly, the PMN (106/200ml)  after washing with
PBS  supplemented  with  0.5 mM  EDTA  were  resus-
pended in ice-cold 70% ethanol and stored at –20°C for
1–2 days.  Then, neutrophils were treated with RNase A
(10mg/ml) and stained with 20mg/ml of PI. Cells were
held in the dark at room temperature for 15min and
then stored at 4°C until flow cytometric analysis. The
fluorescence of individual nuclei was measured using
Cell  Quest  software  for  cell  acquisition  and  data
analysis.  The  percentage  of  apoptotic  cell  nuclei
(located  as  a  hypodiploid  DNA  peak  in  the  DNA
fluorescence histogram) was calculated (Fig. 1B).
Statistical analysis
The  results  are  expressed  as  the  mean  ±  standard
deviation  (SD)  of  at  least  five  independent  experi-
ments. Evaluation of statistical significance was per-
formed by Wilcoxon’s signed rank test. p £ 0.05 was
considered significant.
Results
The  significant  increase in  MTT  reduction  by  neu-
trophils in the presence of  M-ENK and b-END was
observed  both  before  and  after  the  culture.  That
reflects directly the degree of stimulation induced by
M-ENK  and  b-END.  However,  the  ability  of  neu-
trophils to reduce the MTT salt to formazan decreased
significantly  after  the  culture  (Table  1). TNF-a and
PMA were used as the potent receptor-dependent and
Opioid peptides and functional state of neutrophils
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FIG. 1. An example of the quantitation of apoptosis using flow cytometry. (A) Typical dot plot diagram of ANX-FITC/PI flow
cytometry of cells undergoing apoptosis. The lower left quadrant shows the viable cells, which exclude PI and are negatives
for ANX-FITC binding. The lower right quadrant represents the early apoptotic cells,  ANX-FITC  positive and PI negative,
demonstrating cytoplasmic membrane integrity. The upper right quadrant contains the non-viable, necrotic or late apoptotic
cells, positive for ANX-FITC binding and for PI uptake. The data are presented as the sum of percentage of cells located in the
lower right and the upper right quadrants. (B) Histogram of cells analyzed for PI fluorescence (DNA content). The histogram
shows the appearance of the apoptotic region (indicated by arrow) for cells undergoing apoptosis.receptor-independent  stimulators  of  the  oxidative
burst of neutrophils. Figure 2A,B shows a representa-
tive experiment in which 10–6 M of opioid peptides
has been used. The data are given as the mean and SD
of  optical densities at 540  and 620nm  for  separate
experiments. Incubation of neutrophils together with
M-ENK, b-END and opioid-receptor antagonist nalox-
one (10–6 M/ml) did not reveal any differences in their
effect  on  MTT  reduction.  MTT  reduction  by  neu-
trophils stimulated with M-ENK was 0.416  ± 0.294
versus 0.414  ± 0.282  and with b-END was 0.345 ±
0.271 versus 0.346 ± 0.260 in the presence or not of
naloxone, respectively. Naloxone administered alone
had no effect on MTT reduction. Figure  1A,B  illus-
trates the method of neutrophil apoptosis detection
and evaluation. The percentage of apoptotic PMN in
culture treated with M-ENK and b-END evaluated by
flow cytometry is presented in Table 2. The effects of
M-ENK  and  b-END  on  neutrophil  apoptosis  were
dependent on the time of culture and doses of opioids
used.  Treatment  of  the  neutrophils  with  M-ENK
caused a significant increase in the cells binding ANX-
FITC and PI after 18h of culture, while the treatment
with b-END caused a significant increase in apoptotic
cells after 12h of culture. The data are presented as
the  mean  of  the  percentage  of  the  sum  of  cells
binding Annexin V (ANX-FITC+/PI– and ANX-FITC+/
PI+), as shown in Fig. 1A.
To evaluate the possibility that ROS released from
neutrophils  stimulated  with  opioid  peptides  may
promote the death of PMN by apoptosis, the effect of
exogenous  antioxidants  such  as  SOD  and  CAT  on
neutrophil  survival  in  vitro was  investigated. As  a
positive  control of  the  activation-induced model  of
neutrophil apoptosis, the cells treated with PMA were
used. PMA is a receptor-independent stimulator of a
nicotinamide  adenine  dinucleotide  phosphate  oxi-
dase  that  activates  neutrophils  to  release  a  high
amount of H2O2 and O2
– and lead to subsequent cell
death. As presented in Table 3, the presence of SOD
(300U/ml) and CAT (1200U/ml) in the culture media
markedly inhibited the spontaneous neutrophil apop-
tosis.  However,  catalase  did  not  modify  the  PMA-
induced  apoptosis.  We  observed  that  the  percent
inhibition of M-ENK-treated neutrophil apoptosis by
SOD  was  significantly  lower  compared  with  non-
treated neutrophil: 42%, 44% and 54%, respectively.
This effect was most apparent when apoptosis was
measured  using  flow  cytometric  analysis  of  DNA
content. CAT  resulted  in  48%  inhibition  of  sponta-
neous  apoptosis  and  this  effect  was  significantly
attenuated  in  the  presence  of  b-END  (10–10M).
However, no significant differences in the inhibition
of apoptosis by SOD and CAT between untreated and
Z. Sulowska et al.
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Table 1. The effect of opioid peptides on MTT reduction in vitro
Stimulator Time of culture
1h 18h
Stimulator Time of culture
1h 18h
Control 0.44 ± 0.29 0.11 ± 0.09 Control 0.49 ± 0.27 0.14 ± 0.10
M-ENK, 10
–6 M 0.49 ± 0.29* 0.11 ± 0.10 B-END, 10
–6 M 0.53 ± 0.29* 0.14 ± 0.10
M-ENK, 10
–8M 0.48 ± 0.28* 0.11 ± 0.10 B-END, 10
–8 M 0.54 ± 0.29* 0.14 ± 0.11
TNF-a, 10ng/ml 0.55 ± 0.24* 0.11 ± 0.10 TNF-a, 10ng/ml 0.60 ± 0.23* 0.12 ± 0.10
PMA, 100ng/ml 0.62 ± 0.18* 0.09 ± 0.01 PMA, 100ng/ml 0.62 ± 0.18* 0.09 ± 0.01
The data are given as the mean ± SD of optical density as described in Materials and methods. *Statistical significance, p £  0.05 versus control
at time 0.
FIG.  2.  A  representative experiment of  MTT  reduction  by
neutrophils treated with 10
–6M of opioid peptides before and
after culturing in vitro. The potency of PMN to produce ROS
as  their  ability  to  reduce  the  tetrazolium  salt  MTT  to
formazan  was  measured  as  described  in  Materials  and
methods. Briefly, neutrophils (2 ´ 10
5/well) were placed in
96-well plates in 150ml of RPMI 1640 with 10% of FCS and
M-ENK and/or b-END (10
–6M). Then, 50ml of MTT solution in
PBS (1mg/ml) was added to each well. In experiments with
cultured neutrophils at the end of the culture period, the MTT
solution was added to each well. The plates were centrifuged
at 1000rpm for 1min and incubated for 1h at 37°C and 5%
CO2. Formazan produced by PMN in each well was dissolved
in 100ml of 2-propanol. The data are presented as the mean
and SD of optical densities.opioid peptide-treated neutrophils were found when
apoptosis was measured using ANX-FITC/PI binding.
Discussion
PMN have a limited life span in vivo and in vitro, and
the  various  mediators  can  initiate  the  apoptosis
process in these cells. PMN can recognize the opioid
peptides  via  different  classes  of  classical  type  of
opioid receptor27 or by a non-opiate-specific recep-
tor.8,29 The life span and functional activity of mature
PMN can be extended and modified in vivo and in
vitro by numerous agents such as pro-inflammatory
cytokines,  including  granulocyte-colony  stimulating
factor,  interleukin-1,  interleukin-8,  lipopolysacchar-
ide,  and TNF-a.26,30–34 The  results  presented  here
indicate that the opioid peptides, like other inflamma-
tory mediators present at sites of inflammation, may
modulate the survival of neutrophils. An association
between  ROS  released  from  neutrophils  and  the
lifetime  of  neutrophils,  which  is  thought  to  be
connected with induction of  the apoptosis process
was observed.14,15,35 It was also demonstrated that
the presence of ROS,  released from  primed and/or
activated  neutrophils,  accelerates  the  apoptosis  of
neutrophils  themselves  since  the  exogenous  anti-
oxidants added to the culture  medium  significantly
prolonged neutrophil survival.16,17 Narayanan et al.36
suggested that neutrophil apoptosis is in part related
to  the  ability  of  a  cell  to  maintain  an  appropriate
oxidant-antioxidant  balance.  Haberstock  et  al.19,37
demonstrated  that  M-ENK-induced  the  O2
– release
from human neutrophils in dose-dependent fashion.
The  authors  concluded  that  M-ENK-induced  O2
–
release  was  associated with  diacylglycerol  and  the
protein-kinase  C  signal  transduction  pathway.  The
priming  phenomenon  is  referred  to  as  a  process
wherein the response of neutrophils to an activating
stimulus is enhanced considerably by pre-exposure of
cells to the priming  agent.38 Some authors suggest
that most neutrophil priming agents delay apoptosis
and hence increase the survival of neutrophils at the
inflamed site34,39 Pasnik et al.18 and Haberstock and
Marotti19 have  shown  that  M-ENK  and  b-END  in
physiological  concentration  were  involved  in  neu-
trophil priming that resulted in the significant upregu-
lation of chemiluminescence of neutrophil stimulated
with fMLP in vitro. This might suggest the delay of
neutrophil  apoptosis  in  the  presence  of  opioid
peptides. The MTT-reduction assay is one of the tests
with which it is possible to assess the oxidative burst
ability of PMN. Because of the chemical resemblance,
Opioid peptides and functional state of neutrophils
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Table 2. The effect of opioid peptides on spontaneous neutrophil apoptosis in vitro measured by ANX-FITC and PI binding
M-ENK stimulator Time of culture
12h 18h
b-END stimulator Time of culture
12h 18h
0M 63.2 ± 12.4 68.2 ± 14.7 0M 59.7 ± 11.6 68.2 ± 14.8
10
–6 M 66.8 ± 17.7 79.0 ± 10.7* 10
–6 M 68.7 ± 12.0 72.4 ± 8.8
10
–8 M 67.6 ± 14.8 70.4 ± 16.0 10
–8 M 71.3 ± 7.6† 69 ± 15.9
10
–10 M 64.1 ± 19.3 73.0 ± 11.9** 10
–10 M 70.2 ± 11.8†† 70 ± 18.0
Data are presented as mean ± SD of the percentage of the sum of ANX+/PI– and ANX-FITC+/PI+ cells for nine separate experiments. Treatment
of cells with M-ENK caused a significant increase in apoptotic cells after 18h of culture: * 0M (control) versus 10–6 M, p £  0.02; **10–6 M versus
10–10 M, p £ 0.02. Treatment with b-END caused a significant increase in apoptotic cells after 12h of culture: †0M versus 10–8M, p £ 0.03; †† 0M
versus 10–10 M, p £  0.04.
Table 3. Inhibition of spontaneous and opioid peptide-mediated neutrophil apoptosis by exogenous SOD and CAT
Apoptosis assay % Inhibition




Medium alone 41.0 ± 12 32.2 ± 7.5 54.8 ± 19 48.2 ± 9
M-ENK, 10
–8 M 38.2 ± 16 30.0 ± 10 42.6 ± 18* 39.8 ± 19
M-ENK, 10
–10 M 48.4 ± 14 23.5 ± 13 44.8 ± 13* 45.4 ± 18
b-END, 10
–8 M 45.0 ± 9.0 34.5 ± 19 53.0 ± 6 50.2 ± 14
b-END, 10
–10 M 41.4 ± 16 34.5 ± 19 44.0 ± 10 38.2 ± 6**
PMA, 100ng/ml 58.2 ± 11 nd 51.4 ± 18 nd
Opioid peptide-treated and non-treated neutrophils (1 ´ 106/ml/well) were cultured at 37°C in the presence of SOD (300U/ml) or CAT (1200U/ml)
and apoptosis was measured 18h later by flow cytometry, as described in Materials and methods. Results are presented as the mean ± SD of
five separate experiments. % Inhibition of spontaneous  and opioid peptide-mediated apoptosis was calculated as: (1 – % apoptosis in SOD-
treated or CAT-treated neutrophils / % apoptosis in control neutrophils) ´ 100. * p £ 0.05, ** p £ 0.05 compared with medium alone. nd, Not
determined.the mechanism of MTT reduction is similar to that of
nitroblue  tetrazolium.40 We  found  the  significant
increase  in  MTT  reduction  by  neutrophils  in  the
presence of M-ENK and b-END both before and after
the  culture.  It is plausible  that the  decreased MTT
reduction  observed  after  18h  of  the  culture  was
caused by  a progressive increase in the number  of
cells showing the characteristics of apoptotic cells.
These results are consistent with the literature data
showing  that  neutrophil  apoptosis  is  closely  asso-
ciated with its functional impairment.41 Since PMN
progressively became apoptotic during the culture in
the  presence  of  M-ENK  and  b-END,  we  wondered
whether  the  effect  described  was  a  result  of  an
activation of the apoptotic process in these cells by
opioid  peptides  via  ROS  released  from  activated
neutrophils. To verify this hypothesis, we examined
the  effect  of  SOD  and  CAT  added  to  the  culture
medium  on  the  course  of  neutrophil  apoptosis
occurring in the presence of opioid peptides. The fact
that  SOD  and  CAT  protected  neutrophils  against
opioid peptide-induced apoptosis suggests that ROS
may partly be involved in its induction. The present
results show that opioid peptides can regulate neu-
trophil functions via apoptosis and thus may limit the
inflammatory response.
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